A simulated analysis in psoriasis highlights divergent patient and payer incentives and inconsistent coverage strategies behind barriers to phototherapy uptake.

Biocon Biologics is among the leading global suppliers of biosimilar insulins and has been expanding its portfolio ...

Adma Biologics (ADMA) ended the recent trading session at $14.99, demonstrating a -4.34% change from the preceding day's closing price. The stock's change was less than the S&P 500's daily loss of ...

Biologic agents are more expensive to make than chemical drugs like DMARDs. The materials needed to create them cost more, and the manufacturing process, which uses live organisms, is more complex.

Asthma biologic use was not associated with an increase in respiratory infection risk, according to results from the 2026 ...

Just how like finding the perfect shade of foundation or the holy grail of running shoes can take a bit of trial and error, so can finding the right treatment for an autoimmune disease like psoriasis.

AbCellera Biologics (NASDAQ:ABCL) is positioning itself as a more pipeline-driven biotechnology company after more than a decade of platform investment, according to comments from Senior Director of S ...

WuXi Biologics ('WuXi Bio') (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that it has won six prestigious awards and two individual ...

IDBS, a leading provider of cloud software for biopharma companies and a Danaher company, is proud to announce that it has been awarded the Best Biologics Digitalisation: Software Innovation Award, at ...